# ONYX PHARMACEUTICALS INC

ONYX PHARMACEUTICALS INC is a company headquartered in South San Francisco, CA, United States.

## Company overview

- **Legal name:** ONYX PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** South San Francisco, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001012140

## About

ONYX PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001012140, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2013-02-28, it reported annual revenue of USD 362,165,000; net income of USD -187,787,000; total assets of USD 1,351,571,000 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2012 (period ended 2012-12-31)

- **Revenue:** $362.2M (USD 362,165,000)
- **Net income:** -$187.8M (USD -187,787,000)
- **Total assets:** $1.4B (USD 1,351,571,000)
- **Cash and equivalents:** $153.2M (USD 153,244,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $447.2M (USD 447,174,000)
- **Net income:** $76.1M (USD 76,110,000)
- **Total assets:** $1.4B (USD 1,419,537,000)
- **Cash and equivalents:** $171.6M (USD 171,552,000)
- **Operating cash flow:** $50.5M (USD 50,545,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2010 (period ended 2010-12-31)

- **Revenue:** $324.5M (USD 324,515,000)
- **Net income:** -$84.8M (USD -84,847,000)
- **Total assets:** $1.4B (USD 1,352,635,000)
- **Cash and equivalents:** $226.3M (USD 226,340,000)
- **Operating cash flow:** $28.4M (USD 28,357,000)

## Recent SEC filings

- Form 8-K — filed 2013-10-01 — period 2013-10-01 — FORM 8-K
- Form 8-K — filed 2013-09-24 — period 2013-09-24 — 8-K
- Form SC 13G — filed 2013-09-09
- Form 8-K — filed 2013-08-26 — period 2013-08-24 — FORM 8-K
- Form SC 13G — filed 2013-08-19 — SCHEDULE 13G
- Form 10-Q — filed 2013-08-09 — period 2013-06-30 — 10-Q
- Form 8-K — filed 2013-08-08 — period 2013-08-08 — 8-K
- Form 8-K — filed 2013-07-31 — period 2013-07-31 — 8-K
- Form 8-K — filed 2013-07-01 — period 2013-06-30 — 8-K
- Form 8-K — filed 2013-05-23 — period 2013-05-23 — 8-K
- Form 10-Q — filed 2013-05-08 — period 2013-03-31 — 10-Q
- Form 8-K — filed 2013-05-07 — period 2013-05-07 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/onyx-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology